Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04487041 · ClinicalTrials.gov registry record · Phase 4
Tfh Dysfunction in HIV and Aging
A Phase 4 study of Human Influenza, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT04487041 is a Phase 4 study of Human Influenza that is actively recruiting participants, run by University of Miami. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04487041, a Phase 4 study of Human Influenza, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people to understand how aging and HIV infection affect the immune responses (body defenses against infection) to the flu vaccine.
Conditions Studied
Interventions
- BIOLOGICAL Standard dose influenza vaccination
- BIOLOGICAL High dose influenza vaccination
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04487041
The ClinicalTrials.gov registry entry for NCT04487041 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Influenza appearing as the primary indexed condition, and to 2 interventions - of which Standard dose influenza vaccination is the first listed.
NCT04487041 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04487041 about?
NCT04487041 is a clinical study titled "Tfh Dysfunction in HIV and Aging". The purpose of this research is to evaluate blood samples from HIV infected and non-HIV infected people to understand how aging and HIV infection affect the immune responses (body defenses against infection) to the flu vaccine.
What is the current status of trial NCT04487041?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2020-10-30. Estimated completion is 2026-12-30.
What conditions does trial NCT04487041 study?
This clinical trial studies the following conditions: Human Influenza.
What interventions are being tested in trial NCT04487041?
The interventions under investigation include: Standard dose influenza vaccination (BIOLOGICAL), High dose influenza vaccination (BIOLOGICAL).
Who is sponsoring clinical trial NCT04487041?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04487041 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.